Compound ID | 926

Update compound information

CB 102930

Synonym(s): CB-102930  |  CB102930

Class: Small molecule antibacterial agent

Agent Type: Synthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-negative
Mechanism of action: Protein synthesis inhibitor. Aminoacyl-tRNA synthetase inhibitor (phenylanalyl-tRNA synthetase [PheRS] inhibitor)
Institute where first reported: Cubist Pharmaceuticals (Merck & Co, USA)
Year first mentioned: 2001
Highest development stage: Preclinical
Development status: Experimental
Chemical structure(s):
Click here for structure editor
Molecular weight: 492.31
Iso. SMILES: ClC=1C(Cl)=CC(=CC1)N2C(=O)[C@H]3[C@@H](C2=O)C4(O[C@H]3C5=CC=CC=C5)C(C6=CC=CC=C6C4=O)=O
InChI Key: SJMOHJFCZHUNAC-ACRUOGEOSA-N
Can. SMILES: C1=CC=C(C=C1)[C@H]2[C@@H]3[C@@H](C(=O)N(C4=CC=C(C(=C4)Cl)Cl)C3=O)C5(C(=O)C6=C(C=CC=C6)C5=O)O2
InChI: InChI=1S/C26H15Cl2NO5/c27-17-11-10-14(12-18(17)28)29-24(32)19-20(25(29)33)26(34-21(19)13-6-2-1-3-7-13)22(30)15-8-4-5-9-16(15)23(26)31/h1-12,19-21H/t19-,20-,21-/m0/s1
External links:
Citation: https://www.drugfuture.com/synth/syndata.aspx?ID=288178

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.